Avelas Biosciences Inc - San Diego, California 92121

Avelas Biosciences Inc is categorized under Doctors in San Diego, CA .

Business Name: Avelas Biosciences Inc
Contact Person: Paul Finnegan
Address: 5626 Oberlin Drive # 100, San Diego, California 92121
Phone Number: (858) 824-9031
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Pollack Robert B MD - San Diego, CA 92121
Young Philip E MD - San Diego, CA 92121
Ghouri Ahmed F MD - San Diego, CA 92121
Levin Wendy MD - San Diego, CA 92121
Giesemann Lesley A MD - San Diego, CA 92121
Motwani Lasik Institute - San Diego, CA 92121
Maurice Buchbinder Md - San Diego, CA 92121
Shore Brian MD - San Diego, CA 92121
Park Susan MD - San Diego, CA 92121
Vance Matthew P MD - San Diego, CA 92121
Peterson Jennifer D MD - San Diego, CA 92121
Zupancic Michael MD - San Diego, CA 92121
Pikus Mary MD - San Diego, CA 92121
Nguyen Doug T MD - San Diego, CA 92121
Bailey William R DO - San Diego, CA 92121
Vincent P Marin Md - San Diego, CA 92121
Chasen Paul MD - San Diego, CA 92121
Slater Daniel MD - San Diego, CA 92121
Moon Michael MD - San Diego, CA 92121
Lozano Tanya MD - San Diego, CA 92121

The company Avelas Biosciences Inc provides B2C services in the form of Doctors from its single location in California. 1 to 4 employees work for Avelas Biosciences Inc, and the business now earns $100.000 to $499.999 per annum.

Avelas Biosciences Inc was launched in 2008 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Avelas Biosciences Inc, please call Paul Finnegan with the phone number (858) 824-9031 or visit its single location at 5626 Oberlin Drive # 100 in San Diego, California 92121.

The location of the single location can also be found using the coordinates 32.892038,-117.196693. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.